Prudent Corporate Advisory Services Ltd FY2026 Financial Results and Dividend Announcement

Prudent Corporate Advisory Services Limited has announced its financial results for the quarter and year ended March 31, 2026, reporting a robust performance. The company has recommended a final dividend of ₹3.50 per equity share for the fiscal year. Additionally, the board approved the re-appointment of its internal auditor and the appointment of a new non-executive, non-independent director, Mr. Chirag Ashwinkumar Shah, effective July 22, 2026.

Financial Performance Overview

For the financial year ended March 31, 2026, the company delivered strong growth. On a consolidated basis, the total revenue reached ₹1,34,060.06 lakhs, with a net profit of ₹22,205.25 lakhs. Standalone results were equally positive, with total income for the year recorded at ₹1,28,445.02 lakhs and a profit after tax of ₹21,660.34 lakhs. This growth reflects the company’s sustained momentum in its core wealth management business.

Final Dividend Recommendation

Recognizing the value delivered to shareholders, the Board of Directors has recommended a final dividend of ₹3.50 per equity share. This dividend, based on a face value of ₹5 per share, is subject to the necessary approvals by the shareholders during the company’s upcoming Annual General Meeting.

Strategic Updates and Appointments

The company continues to focus on strengthening its corporate governance and operational oversight. The board has approved the re-appointment of M/s. PramodKumar Dad & Associates as the internal auditor for the 2026-27 financial year. Furthermore, the company announced the appointment of Mr. Chirag Ashwinkumar Shah as a Non-Executive, Non-Independent Director, effective July 22, 2026. Mr. Shah brings extensive experience in the insurance and compliance sectors to the board.

Acquisition Impact

The company successfully completed the acquisition of the mutual fund distribution business of Indus Capital on a slump sale basis effective October 1, 2025. This strategic move for an aggregate consideration of ₹12,375 lakhs has already begun contributing to the company’s performance, generating commission income of ₹1,110.98 lakhs during the 2025-26 fiscal year.

Source: BSE

Previous Article

Mankind Pharma Board Meeting Scheduled to Approve Financial Results

Next Article

CCL Products (India) Limited Board Approves Financial Results and Dividend Announcement